<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T20:43:19+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>HIV治疗变革！首款完整长效HIV疗法获FDA批准，每月只需注射1次</title>
    <updated>2021-01-22T17:45:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/-6Gn0xMfQTmcYKlg5zDR-w</id>
    <link href="https://mp.weixin.qq.com/s/-6Gn0xMfQTmcYKlg5zDR-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降糖效果更优！诺和诺德向FDA递交司美鲁肽新规格上市申请</title>
    <updated>2021-01-22T17:45:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/JhdeQykEf03_px2lADG9Zg</id>
    <link href="https://mp.weixin.qq.com/s/JhdeQykEf03_px2lADG9Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞JAK1抑制剂拟纳入突破性疗法，治疗中重度特应性皮炎</title>
    <updated>2021-01-22T17:45:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/n6-Yirsyoc1ooOx6A__j8A</id>
    <link href="https://mp.weixin.qq.com/s/n6-Yirsyoc1ooOx6A__j8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>优效于度普利尤单抗，艾伯维乌帕替尼治疗特应性皮炎上市申请拟纳入优先审评</title>
    <updated>2021-01-22T17:45:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/O9UvUGgXI3-LJS6tUTD8pg</id>
    <link href="https://mp.weixin.qq.com/s/O9UvUGgXI3-LJS6tUTD8pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK HIV复方制剂上市申请拟纳入优先审评</title>
    <updated>2021-01-22T17:45:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/YQTxQoaocQcsAyvyJvrAxQ</id>
    <link href="https://mp.weixin.qq.com/s/YQTxQoaocQcsAyvyJvrAxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州「司妥昔单抗」上市申请拟纳入优先审评</title>
    <updated>2021-01-22T17:45:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/HdYdLwKE38GbVyFmqQNQWA</id>
    <link href="https://mp.weixin.qq.com/s/HdYdLwKE38GbVyFmqQNQWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>挑战K药失败！默克终止M7824一线治疗NSCLC III期研究</title>
    <updated>2021-01-21T17:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/WUNG2kO_SqeO8xmb7iYByg</id>
    <link href="https://mp.weixin.qq.com/s/WUNG2kO_SqeO8xmb7iYByg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田高血压新药「美阿沙坦钾片」在中国获批上市</title>
    <updated>2021-01-21T17:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/nyVaivBbu0rpjDqwTDxdkA</id>
    <link href="https://mp.weixin.qq.com/s/nyVaivBbu0rpjDqwTDxdkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来雷莫芦单抗在中国递交上市申请，用于治疗胃癌</title>
    <updated>2021-01-21T17:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/ufmTqGm2DdoMeFKPk2420Q</id>
    <link href="https://mp.weixin.qq.com/s/ufmTqGm2DdoMeFKPk2420Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田「布格替尼片」中国上市申请获受理，治疗NSCLC</title>
    <updated>2021-01-21T17:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/FSgm1NXVUNSBSBahe0ETaQ</id>
    <link href="https://mp.weixin.qq.com/s/FSgm1NXVUNSBSBahe0ETaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物信迪利单抗+贝伐珠单抗一线治疗肝细胞癌上市申请拟纳入优先审评</title>
    <updated>2021-01-21T17:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/SChJrZIFOr5SBKthptdAvA</id>
    <link href="https://mp.weixin.qq.com/s/SChJrZIFOr5SBKthptdAvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥拉帕利新适应症上市申请拟纳入优先审评，治疗前列腺癌</title>
    <updated>2021-01-21T17:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/yXePjtm3amaXN9WDc69zeQ</id>
    <link href="https://mp.weixin.qq.com/s/yXePjtm3amaXN9WDc69zeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拜耳/默沙东抗心衰新药vericiguat获FDA批准上市</title>
    <updated>2021-01-20T18:48:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/mc24uto79PhcE5pKGi5rpA</id>
    <link href="https://mp.weixin.qq.com/s/mc24uto79PhcE5pKGi5rpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>troriluzole治疗轻中度阿尔茨海默症II/III期临床研究失败</title>
    <updated>2021-01-20T18:48:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/qeAjaf33EwJivx7VhEH6IA</id>
    <link href="https://mp.weixin.qq.com/s/qeAjaf33EwJivx7VhEH6IA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田罕见病新药soticlestat获CDE拟突破性疗法认定</title>
    <updated>2021-01-20T18:48:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/8nmgpum-eTqG7ETYVnw85A</id>
    <link href="https://mp.weixin.qq.com/s/8nmgpum-eTqG7ETYVnw85A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和铂医药巴托利单抗获CDE拟突破性疗法认定</title>
    <updated>2021-01-20T18:48:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/Ehsn9mg3KOOojCLeuUdWIg</id>
    <link href="https://mp.weixin.qq.com/s/Ehsn9mg3KOOojCLeuUdWIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康呼吸道合胞病毒预防药物nirsevimab获CDE拟突破性疗法认定</title>
    <updated>2021-01-20T18:48:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/JjMK80hNRiZ7eWGdefPIFw</id>
    <link href="https://mp.weixin.qq.com/s/JjMK80hNRiZ7eWGdefPIFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>小分子RNA靶向疗法热潮渐起，全球制药巨头纷涌而至</title>
    <updated>2021-01-19T16:07:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/yBePyjnOCIetg692SqvDrg</id>
    <link href="https://mp.weixin.qq.com/s/yBePyjnOCIetg692SqvDrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博安生物新冠中和抗体完成 I 期临床全部受试者入组</title>
    <updated>2021-01-19T16:07:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/a21EtUlaAfB8FByMElIOwg</id>
    <link href="https://mp.weixin.qq.com/s/a21EtUlaAfB8FByMElIOwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个！博雅辑因CRISPR/Cas 9基因编辑疗法获批临床，治疗β地中海贫血</title>
    <updated>2021-01-19T16:07:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/8jSJ1LFkeKInhsCqeLLs0w</id>
    <link href="https://mp.weixin.qq.com/s/8jSJ1LFkeKInhsCqeLLs0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>